Recent Updates
Recently added Catalysts
SYK Positive Sentiment

Stryker names Nick Mead Vice President, Investor Relations

Key Takeaway: Stryker has appointed Nick Mead as Vice President of Investor Relations, effective May 1, 2026. Mead, who has nearly 20 years of experience within the company, previously served as Vice President of Finance for the Medical division. His appointment is expected to strengthen Stryker's investor relations and support its strategic goals.
Price reaction · baseline $326.1 (2026-03-30 close) · hit pre-market · 1 other SYK headline(s) in the window, move may be shared
day 0 close · peak
+0.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Nick Mead's extensive experience at Stryker enhances investor relations.
  • Strong leadership roles indicate a solid foundation for strategic decision-making.
  • The appointment aligns with Stryker's commitment to delivering shareholder value.

Full Press Release Details

Portage, Michigan, March 31, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today Nick Mead has been appointed Vice President, Investor Relations, effective May 1, 2026.
Mead has nearly 20 years of experience at Stryker, with leadership roles spanning multiple divisions and business units across the company. Most recently, he served as Vice President, Finance for Stryker’s Medical division, where he partnered closely with senior leaders to support commercial strategy, capital allocation and operational execution.
“Nick brings deep institutional knowledge, strong financial expertise and a proven ability to support strategic decision making across the organization,” said Preston Wells, Vice President, Chief Financial Officer, Stryker. “His broad experience across our businesses and his strong relationships with internal and external stakeholders position him well to lead our investor relations function as we continue to execute our strategy and deliver value for shareholders.”
Since joining Stryker, Mead has held a variety of roles across the finance organization, supporting businesses within Endoscopy, Medical and Neurotechnology, Orthopaedics and Spine. Throughout his career, he has played a key role in commercial planning, investment decisions and mergers and acquisitions, supporting growth across implants, capital and service portfolios.
Jason Beach, Vice President, Finance and Investor Relations, has been named Vice President, Group Chief Financial Officer, MedSurg and Neurotechnology. Beach joined Stryker in 2018, serving as Vice President, Finance for Stryker’s Instruments division, where he supported strong business performance and led multiple acquisitions and finance transformation initiatives. He is a proven finance leader, recognized for his strong operational leadership, strategic insight and collaborative approach.
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available atwww.stryker.com.
Contacts

Frequently Asked Questions

Who is the new Vice President of Investor Relations at Stryker?

Nick Mead has been appointed as the new Vice President of Investor Relations.

When does Nick Mead start his new role at Stryker?

Nick Mead's appointment as Vice President of Investor Relations is effective May 1, 2026.

What was Nick Mead's previous position at Stryker?

He served as Vice President of Finance for Stryker's Medical division.

What experience does Nick Mead bring to his new role?

Mead has nearly 20 years of experience and has held various leadership roles at Stryker.

Last updated: Mar 31, 2026